Steve Elms
Affiliations
- at Elevation Oncology Inc. (ELEV), 2024-06-17
- at Adma Biologics Inc. (ADMA), 2024-03-20
- Director at Marker Therapeutics Inc. (MRKR), 2023-06-09
- Director at Zosano Pharma Corp (ZSAN), 2021-06-15
- Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2019-07-15
- Large Shareholder, Director at Loxo Oncology Inc. (LOXO), 2019-02-15
- Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
- Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
- Director at Pernix Therapeutics Holdings Inc. (PTX), 2016-05-31
- Large Shareholder at Viewray Inc. (VRAY), 2016-03-30
- Other at Transenterix Inc. (TRXC), 2016-02-05
- Large Shareholder, Director at T2 Biosystems Inc. (TTOO), 2015-12-09
- Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-04-27
- Director at Cidara Therapeutics Inc. (CDTX), 2015-04-22
- Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
- Director at Ambit Biosciences Corp (AMBI), 2014-09-05
- Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
- Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
- Large Shareholder at Cempra Inc. (CEMP), 2012-02-09
- Director at Map Pharmaceuticals Inc. (MAPP), 2010-05-24
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
MRKR | $1.75 | 1,142,857 | Director | 3,142,857 | 2021-03-16 | Filing | |
LOXO | $13.00 | 413,077 | Large Shareholder, Director | 3,452,493 | 2014-08-06 | Filing | |
AMBI | $8.00 | 423,635 | Director | 1,546,444 | 2013-05-21 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
ADMA | $6.08 | 411,829 | 2,115,671 | 2024-03-19 | Filing | ||
ADMA | $6.01 | 49,887 | 2,527,500 | 2024-03-18 | Filing | ||
ADMA | $6.01 | 183,008 | 2,577,387 | 2024-03-15 | Filing | ||
ADMA | $6.05 | 448,276 | 2,760,395 | 2024-03-14 | Filing | ||
ADMA | $6.21 | 407,000 | 3,208,671 | 2024-03-13 | Filing |